http://www.reuters.com/article/2013/...93D08Q20130415
TL;DR what ACLU/scholars/'open source information' advocates believe are at stake is your health, and the development of a greater and more widely available regiment of testing and treatment.
but let's be honest, what's really at stake here is..
A group of medical researchers, associations and patients say human genes, including synthetically produced material, should not be patented. They sued in 2009, challenging seven patents owned by or licensed to Myriad on two human genes linked to breast and ovarian cancer. A federal judge said the patents were invalid. An appeals court overruled that decision, and the case landed at the Supreme Court.
Several justices, including Justice Sonia Sotomayor, signaled on Monday that they did not think that the simple process of isolating and removing human genes should be patented. But others, such as Justice Elena Kagan, indicated concerns about the impact a broad ruling could have on companies that invest in such research.
Several justices, including Justice Sonia Sotomayor, signaled on Monday that they did not think that the simple process of isolating and removing human genes should be patented. But others, such as Justice Elena Kagan, indicated concerns about the impact a broad ruling could have on companies that invest in such research.
TL;DR what ACLU/scholars/'open source information' advocates believe are at stake is your health, and the development of a greater and more widely available regiment of testing and treatment.
but let's be honest, what's really at stake here is..
The biotechnology industry warns that a broad ruling against Myriad could threaten billions of dollars of investment.
Comment